BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

BALA CYNWYD, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky

Related Keywords

Boston ,Massachusetts ,United States ,Brodsky Smith ,Marc Ackerman ,Johnson ,Ambrx Biopharma Inc ,Axonics Inc ,Nasdaq ,Boston Scientific Corporation ,Harpoon Therapeutics Inc ,Gracell Biotechnologies Inc ,Jason Brodsky ,Ambrx Board ,Gracell Board ,Axonics Board ,Merger Agreement ,Harpoon Board ,